Latest Posts
About This Stock
More About This Stock
Read
Read
Alimera Sciences: Company Achieves Breakeven Pretax Cash Flow In 2Q, 2017 Despite Slow Unit Demand For Iluvien
Article By:
SmithOnStocks
Monday, August 14, 2017 1:42 PM EDT
Alimera has made dramatic improvements in its cash flow situation and has done a very respectable job in building sales. Alimera is not far away from being a cash generating, profitable pharmaceutical company.
In this article: ALIM
Weekly Stock Report
Article By:
E.B. Capital Markets
Tuesday, June 3, 2014 11:03 AM EDT
The top scoring sector remains utilities. Consumer goods, industrial goods, and healthcare also score above average. Financials, services, basics, and technology score below average.
In this article: AN, APH, AVB, AZO, CSX, EQT, GB, GD, LO, NEE, ALIM, ECOL, AGYS, CTRN, ORLY, SIAL, EFA, SPY, XLU, ABBV